Therapeutic Asset Ratings

603 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Inno-206 Monoclonal Gammopathy of Renal Significance	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Inno-206 Thalassemia	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Inno-206 Thalassemia, Beta	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
MOGAMULIZUMAB T-Cell Leukemia	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Monomethyl Fumarate HLH	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Monomethyl Fumarate Inherited Metabolic Disorders	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Monomethyl Fumarate NHL or HL	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Nivolumab Fumarate Hydratase Deficient Renal Cell Carcinoma	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
OMBURTAMAB Desmoplastic Small Round Cell Tumor	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
OMBURTAMAB Peritoneum Cancer	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
OMBURTAMAB Peritoneal Carcinoma	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Pembrolizumab Refractory	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Pembrolizumab Relapsed	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Pirtobrutinib Lymphoplasmacytic Lymphoma	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Plerixafor Diffuse Large B-Cell Lymphoma	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Plerixafor Recurrent Adult Diffuse Large Cell Lymphoma	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Plerixafor Refractory Diffuse Large B-cell Lymphoma (DLBCL)	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Plerixafor Relapsed/Refractory Diffuse Large B-Cell Lymphoma	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Polatuzumab High Grade B-Cell Lymphoma	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
POLY((N-(2-HYDROXYPROPYL)METHACRYLAMIDE)-CO-(METHACRYLOYL-GLY-PHE-LEU-GLY AMIDE WITH O-((TRANS-4-AMINOCYCLOHEXYL)CARBAMOYL)FUMAGILLOL)) (~0.91:0.09 X) Triple-Negative Breast Carcinoma	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
PREDNISONE TABLETS Monoclonal Gammopathy of Renal Significance	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
PREDNISONE TABLETS Thalassemia, Beta	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Romidepsin Hemophagocytic Lymphohistiocytosis	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Romidepsin Inherited Metabolic Disorders	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Romidepsin NHL or HL	Memorial Sloan Kettering Cancer Center	P2	CCC (53)

Showing 226 to 250 of 603 assets

PreviousPage 10 of 25Next